Javascript DHTML Drop Down Menu Powered by dhtml-menu-builder.com

 


Familial Shar-Pei Fever

(FSF)

Before you read Dr. Vidt's summary below on FSF, let me give you my thoughts.

I have been breeding for over 20 years.

I have had dogs with FSF, in fact I had one die last year at 14 years of age.

IT IS NOT A DEATH SENTENCE.

Many many other breeders agree with me.

FSF  does not automatically mean Amyloidosis

I have an 8 year old that gets them, it lasts for 12 hours and is then gone.

I have had 3 dogs here that died of Amyloidosis, not one of them ever had FSF. Those that I have had FSF, did not die from Amyloidosis.

If your pet gets a bout of FSF, unless the temperature reaches 106-107 (normal is 101) give them an ASCRIPTIN. This brings down the fever and takes away the pain.

DO NOT PANIC, this is not necessarily a death sentence, PLEASE CALL YOUR BREEDER!!!!!!!!!!!!!!!!!!


Written by: Jeff Vidt, DVM

     
Familial Shar-Pei Fever (FSF) is a hereditary inflammatory disorder seen in Shar-Pei. It is inherited as an autosomal recessive condition.

Clinical signs:
Episodic fever is the most important and consistent clinical sign of this disorder. The temperature commonly is in the 105-107°F range. The fever is generally self-limiting lasting 12-36 hours. Another common clinical sign often accompanying the fever is swelling of a joint, usually the hock (tibiotarsal) joint and is known as Swollen Hock Syndrome (SHS). This painful, hot swelling can also involve the carpus (wrist) and the lips. Dogs with FSF are sick -- they are reluctant to move and when they do walk they have a characteristic "walking on eggs" gait. They often are painful in the abdomen and have a characteristic "roached" back.

Pathogenesis:
What we do know about this disease is as follows:

  1. Shar-Pei with FSF have increased levels of the cytokine Interleukin-6 (IL-6). IL-6 is involved with the fever response and and is an integral part of triggering the production of Acute Phase Reactant Proteins by the liver. IL-6 is also involved in the Systemic Inflammatory Response Syndrome (SIRS). Dysregulation of IL-6 is the cause of much of the disease in Shar-Pei with FSF. IL-6 also plays a major role in the body's stress response and serves to "prime" the immune system.
  2. Shar-Pei with FSF are at risk from early death from systemic amyloidosis. About 25% of the FSF dogs will develop renal failure including renal amyloidosis -- a smaller percentage will develop hepatic amyloidosis. This is usually seen in Shar-Pei between the ages of 2-5 years of age. They also seem more susceptible to immune-mediated kidney disease such as membranous glomerulonephritis, protein-losing glomerulopathies, DIC, thromboembolic phenomena such as mesenteric, splenic and pulmonary embolism and Streptococcal Toxic Shock Syndrome (STSS).
  3. FSF in Shar-Pei was hypothesized to be an animal model of Familial Mediterranean Fever (FMF) in humans. Recent work indicates this is not true, although FSF is very similar to FMF in man.
  4. FSF is a heredofamilial disease with a genetic basis. It appears to be inherited as an autosomal recessive condition.


Laboratory Findings:
Unfortunately there are no blood test, etc. which are specific for FSF. During a fever episode there will often be an increased white blood cell count, an increase in liver enzyme levels and other non-specific findings. Work done by Dr. Gary Johnson at the University of Missouri College of Veterinary Medicine to develop a DNA blood test to screen for the disease was unsuccessful and the research effort will still continue.

Treatment:
It is very important to monitor the temperature in this condition. Initially, fever can be treated using aspirin. Usually a regular strength adult aspirin is given every 6 hours for the first 24 hours and then twice a day for 3-5 day thereafter. In rare cases where aspirin doesn't work of for extremely high fevers, dipyrone is given. Some patients will require supportive care with intravenous fluid therapy and in extreme cases emergency treatment similar to heat stroke treatment. Antibiotics are not normally indicated in this condition.

Colchicine:
Colchicine is a drug that has been in use in people with FMF to prevent amyloidosis. It is currently being recommended in Shar-Pei with FSF for the same purpose. No studies have been completed to determine if it is useful for this purpose in the Shar-Pei or not. The clinical impression is that it does help. Those dogs on colchicine seem to have fewer FSF episodes and less severe signs while on the drug. Side-effects appear to be minimal at this time and are primarily gastrointestinal such as vomiting, diarrhea, anorexia (decreased appetite), etc.

Prevention:
Shar-Pei with FSF only show symptoms sporadically. It would appear that there are "triggers" involved in initiation of the FSF episodes. One of the major triggers appears to be stress. This may be a dog training class, a dog show, another illness, a dog in heat, excessive exercise, etc. If the owner can recognize these triggers and take steps to avoid them the number of FSF episodes can often be reduced. Diet does not appear to be helpful in prevention of FSF or kidney disease. Surely diet has a role in the management of the kidney disease once clinical signs are apparent. Low dose aspirin therapy may be useful in decreasing the incidence of FSF and its severity as well. Aspirin may also be useful as an adjunct therapy in the prevention of thromboembolism.


Monitoring:
Monitoring for the complications which often accompany FSF is one of the major goals of the owner of an FSF dog. The primary and most consistent sequela to FSF is kidney failure either due to immune-mediated kidney disease or renal amyloidosis. I currently recommend monitoring a urinalysis every 3 months. The sample should be collected first thing in the morning after the water has been taken up overnight. I primarily look at the urine specific gravity which is a measure of the concentration of the urine and the protein levers in the urine. When the kidneys begin to fail the initial indication is a loss in the ability to produce a concentrated urine. This occurs before there are blood changed related to kidney failure. Increased water consumption, increased urination are the clinical signs associated with the loss of concentrating ability, but these signs are often not recognized. I also thing it is wise to do a blood panel every 6-12 months and certainly do one in the urinalysis is abnormal. Weighing your dog periodically is very important. We often don't recognize a significant weight loss because it is very subtle over a longer period of time. Water consumption and appetite are other important indicators to watch.

Complications of FSF:
We have already discussed the kidney complications in this condition. Other Complications which have been documented include thromboembolism (mesenteric, splenic, pulmonary), DIC (disseminated intravascular coagulation), SIRS (systemic inflammatory response syndrome), MODS (multiple organ dysfunction syndrome), STSS (streptococcal toxic shock syndrome), hypertension associated with renal failure. Many of the deaths following an acute FSF episode are due to these complications. No FSF episode should be treated lightly!

Diagnosis:
There is no specific diagnostic test for FSF at this time. Diagnosis is based on the clinical sign of episodic fever in a Shar-Pei. I think every Shar-Pei that dies should be autopsied to determine the cause of death, but this is even more critical in cases involving FSF. Renal amyloidosis can only be diagnosed based on kidney biopsy and staining with Congo Red stain. This stain is specific for the presence of amyloid. Amyloid has been found in other tissues in Shar-Pei as well so special staining should be requested on all tissues submitted for histopathology.
Many dogs with FSF will not have amyloid in the tissues at the time the tissues were harvested -- this means the absence of amyloid in a biopsy specimen does not mean that dog will not or would not have gone on to develop amyloidosis at a later time. To further confuse the issue, not all Shar-Pei with amyloidosis have shown signs of FSF.

Future:
Research is currently underway at the University of Missouri College of Veterinary Medicine by Dr. Gary Johnson to develop a DNA blood test. The gene for human FMF was sequenced in the Fall of 1997 and with that information Dr. Johnson had hoped to sequence the FSF gene. That information was applied by Dr. Gary Johnson to FSF in a research project founded by the CSPCA Charitable Trust. That project did determine that the mutations causing FMF in man do not exist in FSF in the Shar-Pei, hence they are two distinct, although similar diseases. There are other hereditary inflammatory fever disorders in man and Dr. Kastner ant the National Institutes of Health are looking at the disorder with information supplied by Dr. Tintle. Familial Hibernian Fever in man has also been ruled out as the cause of FSF by Dr. Johnson with information supplied by NIH. Work will continue to find the genetic mutation(s) responsible for FSF in Shar-Pei.

As of this writing the mutation responsible for FSF has not been found. If a test can be developed, a screening program can be established to screen breeding stock and determine normal individuals, carriers and affected dogs. With this information Shar-Pei breeders can gradually eliminate this genetic disease from the breed. One of the major obstacles to research revolves around the unpredictable phenotype of FSF. There is no consistent age range when clinical signs develop, the clinical signs can be variable, some dogs develop amyloidosis, some don't, etc. This makes it very difficult to use genetic selection methods which are based on phenotype.

Recommendations:
All Shar-Pei with FSF should be on colchicine and be regularly monitored via urine samples and blood work for development of complications. Dogs with FSF should not be used in breeding programs and should be neutered. Dogs with a family history of FSF should be on colchicine and monitored. Dogs with FSF should be maintained as stress-free as possible.



Dr. Linda Tintle

UPDATE ON RESEARCH AND REQUEST FOR SAMPLES FROM DOGS WITH FSF DURING A FEVER EVENT AS WELL AS IN BETWEEN FSF EPISODES

 As  part of our CSP Charitable Trust-AKC/CHF funded study, Dr. Anne Avery is looking for blood samples from dogs with FSF (Familial Shar-Pei Fever) at the time they are spiking a fever.  Please have your veterinarian obtain 6-10 ml of EDTA whole blood (lavender top tube) and the serum from 3-5 ml blood (red top or serum separator tube) and contact Dr. Avery at (970) 491-1170 to arrange overnight shipment of the samples to: Dr. Anne Avery, Dept. of MIP, 1619 Campus Delivery, Fort Collins, CO 80523-1619 by overnight express.  You will need to provide a signed consent form, the dogs AKC number and complete a questionnaire which can be faxed or e-mailed to you.  Shipping costs via UPS will be covered by the research grant an (account number will be provided for billing) but there is no funding available to reimburse you for veterinary expenses.  Please help.  She also still needs samples from ANY dog with a history of FSF episodes.  Your cooperation will benefit your dog and the entire breed.   

Preliminary results have shown that a statistically significant greater number of Shar-Pei with FSF or Shar-Pei with close relatives with FSF/A have elevated background levels of IL-6.  Shar-Pei without evidence of FSF and no close relatives with FSF/A did not have statistically significantly elevated background levels of IL-6.  This was shown in my study with Cornell and confirmed by Dr. Avery's recent testing.  So far, it looks like SAA and CRP levels are all over the place and do not correlate with health or disease but analysis is on-going. Also, no Shar-Pei (with or without FSF) that Dr. Avery examined had elevated levels of TNF-á.  Serum IL-10 and HA (hyaluronan or mucin) levels are next.  We do not know yet if serum HA levels correlate with their auto-inflammatory disease.  All we can do at this time is speculate which is why that research is a priority.  I am also working to get Dr. Avery's study to include checking levels of IL-1â as soon as possible because this has been implicated in some of the human periodic fever disorders.  Since IL-6 is one of the main chemical signals to turn on the acute phase reactant proteins (the precursors of amyloid A), chronic elevation of IL-6 in FSF patients is not a surprising finding.  My study with immunologists Ariel Rivas and Fred Quimby at Cornell in the early '90s suggested that there may be problem with down-regulation of IL-6 so we are going to take another look at that (a blocked receptor for an IL-6 inhibitor?)  

The studies are as yet incomplete.  S-P had dramatically elevated levels of IL-6 and SAA during fever events.  We are looking for samples from more dogs during events (see above).  These elevations are not unexpected because these are the messengers of inflammation but we want to compare their response to normal controls to see if they are exaggerated.   

The problem with IL-6 as a test is that not every dog with FSF had elevated background levels - there may be a lot of false negatives so I don't know how useful it might prove as a diagnostic test. One of the other cytokines yet to be examined may prove to be more predictive.  A specific genetic mutation that is shared by all Shar-Pei with FSF would be ideal the elusive holy grail of tests.  Linkage studies for this will be starting as soon as we can get all the information possible on the dogs in the pedigrees being examined by Dr. Puppo at the NIH. (Very soon). 

My heartfelt thanks to Barbara LaVere, Pat Zimmel-Roach, Alice Fix, Dr. Jeff Vidt and all the members of the Centennial Club in the Colorado area (too numerous to list but without which Dr. Avery's project would not be moving forward!) and the many CSPCA members who have so kindly taken the time to provide information for the pedigree analysis component of the DNA study at the NIH.  Dr. Avery told me today how enormously impressed she is by the lengths to which Shar-Pei breeders have been willing to go to help with this project.  Shar-Pei people are as special as their dogs! 

Dr. Linda Tintle
Wurtsboro Veterinary Clinic
163 Sullivan Street, PO Box 910
Wurtsboro
, New York 12790
wvc@warwick.net

www.wvc.vetsuite.com

 April 14, 2006

Royal Shar-Pei is Created and maintained by  WebMagination
Copyright © 1994-2010
All rights reserved and may not be used without express permission.